3 lead counsel jobs found

As a worldwide workforce we are deeply committed to helping solve some of today’s biggest healthcare challenges, offering solutions for patients suffering from life-threatening diseases such as HIV/AIDS, liver disease, oncology and respiratory disease. At our core lies a corporate culture committed to science and patients, and an employee environment that fosters innovation, diversity and a commitment to the personal and professional development of all our colleagues. As we grow, we are continually looking to connect with outstanding individuals who are interested in joining our intellectually stimulating and socially responsible team. Successful colleagues at Gilead come from all backgrounds, have a range of perspectives and thrive in an agile and rapidly evolving environment.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has three approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational medicines in other serious diseases where it has deep insight into causal human biology, such as sickle cell disease, beta thalassemia, pain, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy and APOL1-mediated kidney disease.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has three approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational medicines in other serious diseases where it has deep insight into causal human biology, such as sickle cell disease, beta thalassemia, pain, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy and APOL1-mediated kidney disease.